| OUTLOOK THERAPEUTICS |
| USA |
| Gesundheit |
| US69012T3059 / A4046T |
| 41O (Frankfurt) / OTLK (NASDAQ) |
| FRA:41O, ETR:41O, 41O:GR, NASDAQ:OTLK |
| - |
| https://outlooktherapeuti.. |
|
Outlook Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of innovative monoclonal antibodies for the treatment of various ophthalmic diseases. At the f..
>Volltext.. |
| 22.89 Mio. EUR |
| 46.93 Mio. EUR |
| 1.3 Mio. EUR |
| -62.48 Mio. EUR |
| -37.43 Mio. EUR |
| -0.94 EUR |
| 31.79 Mio. EUR |
| 7.48 Mio. EUR |
| -48.63 Mio. EUR |
| 0.18 |
| - |
| 58% |
| - |
| - |
| - |
| - |
| OUTLOOK THERAPEUTICS, OUTLOOK THERAPEUTIC |
| 26.03.26 |
|
||||
|
||||
|